Chimeric Therapeutics Ltd. 2024 SR
The report outlines Chimeric Therapeutics' commitment to ESG principles, reporting against the World Economic Forum's Stakeholder Capitalism Metrics for the 2024 fiscal year. The company focuses on developing curative cell therapies while maintaining high governance standards, including 100% compliance with ASX Corporate Governance Council recommendations. Key highlights include a workforce of seven employees with 57% female representation and a board with 25% female membership. While environmental metrics like GHG emissions and water consumption are currently deemed non-material due to the company's small scale, Chimeric continues to invest significantly in research and development, totaling 11.1 million AUD in FY24.
Company: Chimeric Therapeutics Ltd.
Sector: Professional & technical services
Country: Australia
Year: 2024
Type: SR
Pages: 10
Back to company
Chimeric Therapeutics Ltd.
ESG Report
The report outlines Chimeric Therapeutics' commitment to ESG principles, reporting against the World Economic Forum's Stakeholder Capitalism Metrics for the 2024 fiscal year. The company focuses on developing curative cell therapies while maintaining high governance standards, including 100% compliance with ASX Corporate Governance Council recommendations. Key highlights include a workforce of seven employees with 57% female representation and a board with 25% female membership. While environmental metrics like GHG emissions and water consumption are currently deemed non-material due to the company's small scale, Chimeric continues to invest significantly in research and development, totaling 11.1 million AUD in FY24.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jul 1, 2023 - Jun 30, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees